Ekso Bionics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

• Ekso Bionics Holdings Inc EKSO.OQ reported a quarterly adjusted loss of 14 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -22 cents. The mean expectation of two analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -10 cents to -6 cents per share.

• Revenue rose 5% to $5.09 million from a year ago; analysts expected $5.05 million.

• Ekso Bionics Holdings Inc's reported EPS for the quarter was a loss of 14 cents​.

• The company reported a quarterly loss of $3.41 million.

• Ekso Bionics Holdings Inc shares had fallen by 14.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 6.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $5.50

This summary was machine generated from LSEG data March 4 at 12:56 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)